Loading…
Learn how to assess assay compatibility, platform dependencies, consumables, regulatory limits, and sourcing risks before committing to a diagnostic workflow.
Learn why laboratories are moving beyond individual assay selection and evaluating platform compatibility, automation, workflow efficiency, and sourcing strategies when purchasing molecular diagnosti…
Alzheimer’s blood testing is moving beyond the question of whether amyloid pathology is present. A 2026 NIH-supported study identified a 34-circRNA blood model that performed comparably to pTau217 fo…
